BOIRON Report issue

For profit Phase 3 Phase 4
Founded: Lyon France (2003)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
2004
NCT00774293
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

BOIRON

Active Ingredients

Drugs in Phase 4 Trials (2)

arnica (1 trial)

bryonia (1 trial)

Drugs in Phase 3 Trials (2)

gelsemium sempervirens (1 trial)

sodium bicarbonate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 3)

Mucositis (Phase 3)

Oropharyngeal Neoplasms (Phase 3)

Stomatitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4